Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia

  • Vázquez, Iria
  • Maicas, Miren|||0000-0003-1404-5552
  • Cervera, José|||0000-0001-8252-1106
  • Agirre, Xabier|||0000-0002-6558-9560
  • Marin-Béjar, Oskar|||0000-0002-6889-6566
  • Marcotegui, Nerea
  • Vicente, Carmen
  • Lahortiga, Idoya
  • Gomez-Benito, Maria
  • Carranza, Claudia
  • Valencia, Ana
  • Brunet, Salut|||0000-0003-0491-1672
  • Lumbreras, Eva
  • Prosper, Felipe|||0000-0001-6115-8790
  • Gomez Casares, Maria Teresa|||0000-0003-0505-5126
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Calasanz, M.J|||0000-0002-0374-3008
  • Sanz, Miguel A..|||0000-0003-1489-1177
  • Sierra Gil, Jorge
  • Odero, María D.
Background: The EVI1 gene (3q26) codes for a zinc finger transcription factor with important roles in both mammalian development and leukemogenesis. Over-expression of EVI1 through either 3q26 rearrangements, MLL fusions, or other unknown mechanisms confers a poor prognosis in acute myeloid leukemia. Design and Methods: We analyzed the prevalence and prognostic impact of EVI1 over-expression in a series of 476 patients with acute myeloid leukemia, and investigated the epigenetic modifications of the EVI1 locus which could be involved in the transcriptional regulation of this gene. Results: Our data provide further evidence that EVI1 over-expression is a poor prognostic marker in acute myeloid leukemia patients less than 65 years old. Moreover, we found that patients with no basal expression of EVI1 had a better prognosis than patients with expression/over-expression (P=0.036). We also showed that cell lines with over-expression of EVI1 had no DNA methylation in the promoter region of the EVI1 locus, and had marks of active histone modifications: H3 and H4 acetylation, and trimethylation of histone H3 lysine 4. Conversely, cell lines with no expression of EVI1 have DNA hypermethylation and are marked by repressive trimethylation of histone H3 lysine 27 at the EVI1 promoter. Conclusions: Our results identify EVI1 over-expression as a poor prognostic marker in a large, independent cohort of acute myeloid leukemia patients less than 65 years old, and show that the total absence of EVI1 expression has a prognostic impact on the outcome of such patients. Furthermore, we demonstrated for the first time that an aberrant epigenetic pattern involving DNA methylation, H3 and H4 acetylation, and trimethylation of histone H3 lysine 4 and histone H3 lysine 27 might play a role in the transcriptional regulation of EVI1 in acute myeloid leukemia. This study opens new avenues for a better understanding of the regulation of EVI1 expression at a transcriptional level.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

EVI1 controls proliferation in acute myeloid leukaemia through modulation of miR-1-2

  • Gómez-Benito, María
  • Conchillo, Ana
  • García, M. A.
  • Vázquez Urio, Iria
  • Maicas, Miren
  • Vicente, Carmen
  • Cristóbal, Ion
  • Marcotegui, Nerea
  • García-Ortí, L.
  • Bandrés Elizalde, Eva
  • Calasanz, María José
  • Alonso, Marta M.
  • Odero, María D.
Acceso cerrado a este documento. No se encuentra disponible para la consulta pública. Depositado en Academica-e para cumplir con los requisitos de evaluación y acreditación académica del autor/a (sexenios, acreditaciones, etc.)., Bakground: the EVI1(ecotropic virus integration site 1) gene codes for a zinc-finger transcription factor, whose transcriptional activation leads to a particularly aggressive form of acute myeloid leukaemia (AML). Although, EVI1 interactions with key proteins in hematopoiesis have been previously described, the precise role of this transcription factor in promoting leukaemic transformation is not completely understood. Recent works have identified specific microRNA (miRNA) signatures in different AML subgroups. However, there is no analysis of miRNAs profiles associated with EVI1 overexpression in humans. Methods: we performed QT-RT-PCR to assess the expression of 250 miRNAs in cell lines with or without EVI1 overexpression and in patient samples. We used ChIP assays to evaluated the possible binding of EVI1 binding to the putative miRNA promoter. Proliferation of the different cell lines transfected with the anti- or pre-miRs was quantified by MTT. Results: our data showed that EVI1 expression was significantly correlated with the expression of miR-1-2 and miR-133-a-1 in established cell lines and in patient samples. ChIP assays confirmed that EVI1 binds directly to the promoter of these two miRNAs. However, only miR-1-2 was involved in abnormal proliferation in EVI1 expressing cell lines. Conclusions: our data showed that EVI1 controls proliferation in AML through modulation of miR-1-2. This study contributes to further understand the transcriptional networks involving transcription factors and miRNAs in AML., This work was supported by Ministerio de Salud (FIS-CD07/00045), Ministerio de Educación y Ciencia (SAF2005/06425), Ministerio de Ciencia e Innovación (PI081687), ISCIII-RETIC (RD06/0020/0078 and RD06/0020/0071), Departamento Salud del Gobierno de Navarra (14/2008), and Fundació para la Investigación Médica Aplicada y UTE (Spain).